{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:30:50Z","timestamp":1792690250027,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10014-016-0271-7","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T08:52:41Z","timestamp":1473756761000},"page":"237-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Genetic landscape of meningioma"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-4000","authenticated-orcid":false,"given":"Sayaka","family":"Yuzawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"271_CR1","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17 Suppl 4:iv1\u2013iv62","DOI":"10.1093\/neuonc\/nov189"},{"key":"271_CR2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1470-2045(11)70275-3","volume":"12","author":"RS Kotecha","year":"2011","unstructured":"Kotecha RS, Pascoe EM, Rushing EJ et al (2011) Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol 12:1229\u20131239","journal-title":"Lancet Oncol"},{"key":"271_CR3","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro Oncol 16 Suppl 4:iv1\u201363","DOI":"10.1093\/neuonc\/nou223"},{"key":"271_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99:379\u2013391","journal-title":"J Neurooncol"},{"key":"271_CR5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/neuonc\/nos013","volume":"14","author":"H Alkemade van","year":"2012","unstructured":"van Alkemade H, de Leau M, Dieleman EM et al (2012) Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol 14:658\u2013666","journal-title":"Neuro Oncol"},{"key":"271_CR6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2011.08.010","volume":"83","author":"S Adeberg","year":"2012","unstructured":"Adeberg S, Hartmann C, Welzel T et al (2012) Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas\u2013clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83:859\u2013864","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"271_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1601-5223.1972.tb01017.x","volume":"71","author":"J Mark","year":"1972","unstructured":"Mark J, Levan G, Mitelman F (1972) Identification by fluorescence of the G chromosome lost in human meningomas. Hereditas 71:163\u2013168","journal-title":"Hereditas"},{"key":"271_CR8","first-page":"812","volume":"80","author":"J Mark","year":"1972","unstructured":"Mark J, Mitelman F, Levan G (1972) On the specificity of the G abnormality in human meningomas studied by the fluorescence technique. Acta Pathol Microbiol Scand A 80:812\u2013820","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"271_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00273305","volume":"14","author":"H Zankl","year":"1972","unstructured":"Zankl H, Zang KD (1972) Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Humangenetik 14:167\u2013169","journal-title":"Humangenetik"},{"key":"271_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1749-6632.1991.tb37776.x","volume":"615","author":"B Fontaine","year":"1991","unstructured":"Fontaine B, Rouleau GA, Seizinger BR et al (1991) Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma). Ann N Y Acad Sci 615:338\u2013343","journal-title":"Ann N Y Acad Sci"},{"key":"271_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515\u2013521","journal-title":"Nature"},{"key":"271_CR12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/2.8.1215","volume":"2","author":"M Sanson","year":"1993","unstructured":"Sanson M, Marineau C, Desmaze C et al (1993) Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 2:1215\u20131220","journal-title":"Hum Mol Genet"},{"key":"271_CR13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791\u2013800","journal-title":"Cell"},{"key":"271_CR14","first-page":"314","volume":"55","author":"M MacCollin","year":"1994","unstructured":"MacCollin M, Ramesh V, Jacoby LB et al (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55:314\u2013320","journal-title":"Am J Hum Genet"},{"key":"271_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"MH Ruttledge","year":"1994","unstructured":"Ruttledge MH, Sarrazin J, Rangaratnam S et al (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180\u2013184","journal-title":"Nat Genet"},{"key":"271_CR16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF02281874","volume":"97","author":"LR Vitis De","year":"1996","unstructured":"De Vitis LR, Tedde A, Vitelli F et al (1996) Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97:632\u2013637","journal-title":"Hum Genet"},{"key":"271_CR17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080","journal-title":"Science"},{"key":"271_CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi M, Bi WL, Aizer AA et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 18:649\u2013655","journal-title":"Neuro Oncol"},{"key":"271_CR19","volume-title":"WHO classification of tumours of the central nervous system","author":"DN Louis","year":"2016","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system. Lyon, France"},{"key":"271_CR20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2016.81","volume":"29","author":"S Yuzawa","year":"2016","unstructured":"Yuzawa S, Nishihara H, Yamaguchi S et al (2016) Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Mod Pathol 29:708\u2013716","journal-title":"Mod Pathol"},{"key":"271_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45:285\u2013289","journal-title":"Nat Genet"},{"key":"271_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Piro RM, Jones DT et al (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125:351\u2013358","journal-title":"Acta Neuropathol"},{"key":"271_CR23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00401-005-0021-0","volume":"111","author":"JC Pang","year":"2006","unstructured":"Pang JC, Chung NY, Chan NH et al (2006) Rare mutation of PIK3CA in meningiomas. Acta Neuropathol 111:284\u2013285","journal-title":"Acta Neuropathol"},{"key":"271_CR24","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3892\/ol.2014.2042","volume":"7","author":"M Bujko","year":"2014","unstructured":"Bujko M, Kober P, Tysarowski A et al (2014) EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas. Oncol Lett 7:2019\u20132022","journal-title":"Oncol Lett"},{"key":"271_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","volume":"6","author":"T Bouwmeester","year":"2004","unstructured":"Bouwmeester T, Bauch A, Ruffner H et al (2004) A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway. Nat Cell Biol 6:97\u2013105","journal-title":"Nat Cell Biol"},{"key":"271_CR26","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1074\/jbc.M111.300137","volume":"287","author":"I Scudiero","year":"2012","unstructured":"Scudiero I, Zotti T, Ferravante A et al (2012) Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFalpha-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J Biol Chem 287:6053\u20136061","journal-title":"J Biol Chem"},{"key":"271_CR27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3892\/or.2012.2121","volume":"29","author":"L Wang","year":"2013","unstructured":"Wang L, Wang L, Zhang S et al (2013) Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer. Oncol Rep 29:283\u2013287","journal-title":"Oncol Rep"},{"key":"271_CR28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C et al (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448:439\u2013444","journal-title":"Nature"},{"key":"271_CR29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.bjc.6604212","volume":"98","author":"MS Kim","year":"2008","unstructured":"Kim MS, Jeong EG, Yoo NJ et al (2008) Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Br J Cancer 98:1533\u20131535","journal-title":"Br J Cancer"},{"key":"271_CR30","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","volume":"68","author":"K Stemke-Hale","year":"2008","unstructured":"Stemke-Hale K, Gonzalez-Angulo AM, Lluch A et al (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68:6084\u20136091","journal-title":"Cancer Res"},{"key":"271_CR31","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/onc.2008.170","volume":"27","author":"FE Bleeker","year":"2008","unstructured":"Bleeker FE, Felicioni L, Buttitta F et al (2008) AKT1(E17K) in human solid tumours. Oncogene 27:5648\u20135650","journal-title":"Oncogene"},{"key":"271_CR32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjc.6605109","volume":"101","author":"K Shoji","year":"2009","unstructured":"Shoji K, Oda K, Nakagawa S et al (2009) The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas. Br J Cancer 101:145\u2013148","journal-title":"Br J Cancer"},{"key":"271_CR33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/onc.2009.315","volume":"29","author":"JM Askham","year":"2010","unstructured":"Askham JM, Platt F, Chambers PA et al (2010) AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Oncogene 29:150\u2013155","journal-title":"Oncogene"},{"key":"271_CR34","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1158\/1078-0432.CCR-13-0884","volume":"19","author":"JA Beaver","year":"2013","unstructured":"Beaver JA, Gustin JP, Yi KH et al (2013) PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system. Clin Cancer Res 19:5413\u20135422","journal-title":"Clin Cancer Res"},{"key":"271_CR35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","volume":"365","author":"MJ Lindhurst","year":"2011","unstructured":"Lindhurst MJ, Sapp JC, Teer JK et al (2011) A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 365:611\u2013619","journal-title":"N Engl J Med"},{"key":"271_CR36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.c.30063","volume":"137c","author":"MM Cohen Jr","year":"2005","unstructured":"Cohen MM Jr (2005) Proteus syndrome: an update. Am J Med Genet C Semin Med Genet 137c:38\u201352","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"271_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"271_CR38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc3582","volume":"13","author":"MP Tetreault","year":"2013","unstructured":"Tetreault MP, Yang Y, Katz JP (2013) Kruppel-like factors in cancer. Nat Rev Cancer 13:701\u2013713","journal-title":"Nat Rev Cancer"},{"key":"271_CR39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.onc.1207067","volume":"23","author":"W Zhao","year":"2004","unstructured":"Zhao W, Hisamuddin IM, Nandan MO et al (2004) Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23:395\u2013402","journal-title":"Oncogene"},{"key":"271_CR40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajpath.2010.11.021","volume":"178","author":"F Zammarchi","year":"2011","unstructured":"Zammarchi F, Morelli M, Menicagli M et al (2011) KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am J Pathol 178:361\u2013372","journal-title":"Am J Pathol"},{"key":"271_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/cdd.2015.85","volume":"23","author":"T Yu","year":"2016","unstructured":"Yu T, Chen X, Zhang W et al (2016) KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ 23:207\u2013215","journal-title":"Cell Death Differ"},{"key":"271_CR42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.1908","volume":"208","author":"F Buttitta","year":"2006","unstructured":"Buttitta F, Felicioni L, Barassi F et al (2006) PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. J Pathol 208:350\u2013355","journal-title":"J Pathol"},{"key":"271_CR43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1078-0432.CCR-05-2173","volume":"12","author":"W Qiu","year":"2006","unstructured":"Qiu W, Schonleben F, Li X et al (2006) PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 12:1441\u20131446","journal-title":"Clin Cancer Res"},{"key":"271_CR44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","volume":"94","author":"B Karakas","year":"2006","unstructured":"Karakas B, Bachman KE, Park BH (2006) Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 94:455\u2013459","journal-title":"Br J Cancer"},{"key":"271_CR45","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1158\/0008-5472.CAN-05-2620","volume":"65","author":"K Oda","year":"2005","unstructured":"Oda K, Stokoe D, Taketani Y et al (2005) High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res 65:10669\u201310673","journal-title":"Cancer Res"},{"key":"271_CR46","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","volume":"64","author":"IG Campbell","year":"2004","unstructured":"Campbell IG, Russell SE, Choong DY et al (2004) Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64:7678\u20137681","journal-title":"Cancer Res"},{"key":"271_CR47","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-06-0292","volume":"12","author":"F Schonleben","year":"2006","unstructured":"Schonleben F, Qiu W, Ciau NT et al (2006) PIK3CA mutations in intraductal papillary mucinous neoplasm\/carcinoma of the pancreas. Clin Cancer Res 12:3851\u20133855","journal-title":"Clin Cancer Res"},{"key":"271_CR48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"102","author":"S Kang","year":"2005","unstructured":"Kang S, Bader AG, Vogt PK (2005) Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102:802\u2013807","journal-title":"Proc Natl Acad Sci USA"},{"key":"271_CR49","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1158\/0008-5472.CAN-04-4114","volume":"65","author":"T Ikenoue","year":"2005","unstructured":"Ikenoue T, Kanai F, Hikiba Y et al (2005) Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65:4562\u20134567","journal-title":"Cancer Res"},{"key":"271_CR50","first-page":"1798","volume":"58","author":"J Reifenberger","year":"1998","unstructured":"Reifenberger J, Wolter M, Weber RG et al (1998) Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798\u20131803","journal-title":"Cancer Res"},{"key":"271_CR51","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.onc.1202360","volume":"18","author":"CW Lam","year":"1999","unstructured":"Lam CW, Xie J, To KF et al (1999) A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18:833\u2013836","journal-title":"Oncogene"},{"key":"271_CR52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11284","volume":"488","author":"DT Jones","year":"2012","unstructured":"Jones DT, Jager N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100\u2013105","journal-title":"Nature"},{"key":"271_CR53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106\u2013110","journal-title":"Nature"},{"key":"271_CR54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","volume":"11","author":"C Bacci","year":"2010","unstructured":"Bacci C, Sestini R, Provenzano A et al (2010) Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 11:73\u201380","journal-title":"Neurogenetics"},{"key":"271_CR55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.2010.082420","volume":"48","author":"I Christiaans","year":"2011","unstructured":"Christiaans I, Kenter SB, Brink HC et al (2011) Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet 48:93\u201397","journal-title":"J Med Genet"},{"key":"271_CR56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10048-012-0335-8","volume":"13","author":"G Melean","year":"2012","unstructured":"Melean G, Velasco A, Hernandez-Imaz E et al (2012) RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas. Neurogenetics 13:267\u2013274","journal-title":"Neurogenetics"},{"key":"271_CR57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","volume":"45","author":"MJ Smith","year":"2013","unstructured":"Smith MJ, O\u2019Sullivan J, Bhaskar SS et al (2013) Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet 45:295\u2013298","journal-title":"Nat Genet"},{"key":"271_CR58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","volume":"234","author":"MJ Smith","year":"2014","unstructured":"Smith MJ, Wallace AJ, Bennett C et al (2014) Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas. J Pathol 234:436\u2013440","journal-title":"J Pathol"},{"key":"271_CR59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3171\/2015.3.PEDS14417","volume":"16","author":"LT Evans","year":"2015","unstructured":"Evans LT, Van Hoff J, Hickey WF et al (2015) SMARCE1 mutations in pediatric clear cell meningioma: case report. J Neurosurg Pediatr 16:296\u2013300","journal-title":"J Neurosurg Pediatr"},{"key":"271_CR60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00381-014-2558-5","volume":"31","author":"H Raffalli-Ebezant","year":"2015","unstructured":"Raffalli-Ebezant H, Rutherford SA, Stivaros S et al (2015) Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case. Childs Nerv Syst 31:441\u2013447","journal-title":"Childs Nerv Syst"},{"key":"271_CR61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-015-0472-y","volume":"17","author":"EH Gerkes","year":"2016","unstructured":"Gerkes EH, Fock JM, den Dunnen WF et al (2016) A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening. Neurogenetics 17:83\u201389","journal-title":"Neurogenetics"},{"key":"271_CR62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1054\/bjoc.2000.1583","volume":"84","author":"U Schmitz","year":"2001","unstructured":"Schmitz U, Mueller W, Weber M et al (2001) INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 84:199\u2013201","journal-title":"Br J Cancer"},{"key":"271_CR63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2012.07.015","volume":"91","author":"M Aavikko","year":"2012","unstructured":"Aavikko M, Li SP, Saarinen S et al (2012) Loss of SUFU function in familial multiple meningioma. Am J Hum Genet 91:520\u2013526","journal-title":"Am J Hum Genet"},{"key":"271_CR64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10689-012-9548-0","volume":"11","author":"C Kijima","year":"2012","unstructured":"Kijima C, Miyashita T, Suzuki M et al (2012) Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Fam Cancer 11:565\u2013570","journal-title":"Fam Cancer"},{"key":"271_CR65","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1038\/sj.onc.1203282","volume":"18","author":"C Wicking","year":"1999","unstructured":"Wicking C, Smyth I, Bale A (1999) The hedgehog signalling pathway in tumorigenesis and development. Oncogene 18:7844\u20137851","journal-title":"Oncogene"},{"key":"271_CR66","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/sj.bjc.6600206","volume":"86","author":"FJ Staal","year":"2002","unstructured":"Staal FJ, van der Luijt RB, Baert MR et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586\u20131591","journal-title":"Br J Cancer"},{"key":"271_CR67","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/WNL.43.7.1436","volume":"43","author":"CJ Lyons","year":"1993","unstructured":"Lyons CJ, Wilson CB, Horton JC (1993) Association between meningioma and Cowden\u2019s disease. Neurology 43:1436\u20131437","journal-title":"Neurology"},{"key":"271_CR68","first-page":"983","volume":"36","author":"J Moura De","year":"2010","unstructured":"De Moura J, Kavalec FL, Doghman M et al (2010) Heterozygous TP53stop146\/R72P fibroblasts from a Li\u2013Fraumeni syndrome patient with impaired response to DNA damage. Int J Oncol 36:983\u2013990","journal-title":"Int J Oncol"},{"key":"271_CR69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.WNL.0000055866.64240.2E","volume":"60","author":"H Kanno","year":"2003","unstructured":"Kanno H, Yamamoto I, Yoshida M et al (2003) Meningioma showing VHL gene inactivation in a patient with von Hippel\u2013Lindau disease. Neurology 60:1197\u20131199","journal-title":"Neurology"},{"key":"271_CR70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jocn.2003.12.022","volume":"12","author":"Y Nakamura","year":"2005","unstructured":"Nakamura Y, Shimizu T, Ohigashi Y et al (2005) Meningioma arising in Werner syndrome confirmed by mutation analysis. J Clin Neurosci 12:503\u2013506","journal-title":"J Clin Neurosci"},{"key":"271_CR71","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S0317167100001128","volume":"27","author":"R Leblanc","year":"2000","unstructured":"Leblanc R (2000) Familial adenomatous polyposis and benign intracranial tumors: a new variant of Gardner\u2019s syndrome. Can J Neurol Sci 27:341\u2013346","journal-title":"Can J Neurol Sci"},{"key":"271_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-1664-8_1","volume":"668","author":"P Igaz","year":"2009","unstructured":"Igaz P (2009) MEN1 clinical background. Adv Exp Med Biol 668:1\u201315","journal-title":"Adv Exp Med Biol"},{"key":"271_CR73","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman MH, Pilarski R, Cebulla CM et al (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856\u2013859","journal-title":"J Med Genet"},{"key":"271_CR74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/neuonc\/noq007","volume":"12","author":"MJ Dougherty","year":"2010","unstructured":"Dougherty MJ, Santi M, Brose MS et al (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 12:621\u2013630","journal-title":"Neuro Oncol"},{"key":"271_CR75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"271_CR76","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0b013e31827f9c5e","volume":"37","author":"BK Kleinschmidt-DeMasters","year":"2013","unstructured":"Kleinschmidt-DeMasters BK, Aisner DL, Birks DK et al (2013) Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37:685\u2013698","journal-title":"Am J Surg Pathol"},{"key":"271_CR77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10014-015-0243-3","volume":"33","author":"K Sugimoto","year":"2016","unstructured":"Sugimoto K, Ideguchi M, Kimura T et al (2016) Epithelioid\/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma. Brain Tumor Pathol 33:137\u2013146","journal-title":"Brain Tumor Pathol"},{"key":"271_CR78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08880018.2014.936058","volume":"32","author":"O Mordechai","year":"2015","unstructured":"Mordechai O, Postovsky S, Vlodavsky E et al (2015) Metastatic rhabdoid meningioma with BRAF V600E mutation and good response to personalized therapy: case report and review of the literature. Pediatr Hematol Oncol 32:207\u2013211","journal-title":"Pediatr Hematol Oncol"},{"key":"271_CR79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13000-016-0506-2","volume":"11","author":"F Behling","year":"2016","unstructured":"Behling F, Barrantes-Freer A, Skardelly M et al (2016) Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11:55","journal-title":"Diagn Pathol"},{"key":"271_CR80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5414\/NP300836","volume":"34","author":"F Forest","year":"2015","unstructured":"Forest F, Yvorel V, Vassal F et al (2015) BRAF V600 point mutation is not present in relapsing meningioma. Clin Neuropathol 34:164\u2013165","journal-title":"Clin Neuropathol"},{"key":"271_CR81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/gcc.2870090411","volume":"9","author":"MJ Bello","year":"1994","unstructured":"Bello MJ, de Campos JM, Kusak ME et al (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9:296\u2013298","journal-title":"Genes Chromosomes Cancer"},{"key":"271_CR82","first-page":"4696","volume":"55","author":"M Simon","year":"1995","unstructured":"Simon M, von Deimling A, Larson JJ et al (1995) Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696\u20134701","journal-title":"Cancer Res"},{"key":"271_CR83","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","volume":"94","author":"RG Weber","year":"1997","unstructured":"Weber RG, Bostrom J, Wolter M et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719\u201314724","journal-title":"Proc Natl Acad Sci USA"},{"key":"271_CR84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","volume":"110","author":"K Lamszus","year":"1999","unstructured":"Lamszus K, Kluwe L, Matschke J et al (1999) Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110:103\u2013110","journal-title":"Cancer Genet Cytogenet"},{"key":"271_CR85","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","volume":"60","author":"DX Cai","year":"2001","unstructured":"Cai DX, Banerjee R, Scheithauer BW et al (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628\u2013636","journal-title":"J Neuropathol Exp Neurol"},{"key":"271_CR86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/neuonc\/nov177","volume":"18","author":"AA Aizer","year":"2016","unstructured":"Aizer AA, Abedalthagafi M, Bi WL et al (2016) A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro Oncol 18:269\u2013274","journal-title":"Neuro Oncol"},{"key":"271_CR87","first-page":"3226","volume":"58","author":"EP Sulman","year":"1998","unstructured":"Sulman EP, Dumanski JP, White PS et al (1998) Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 58:3226\u20133230","journal-title":"Cancer Res"},{"key":"271_CR88","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1309\/D7U997XD2PHBCQCN","volume":"123","author":"MD Tabernero","year":"2005","unstructured":"Tabernero MD, Espinosa AB, Maillo A et al (2005) Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features. Am J Clin Pathol 123:744\u2013751","journal-title":"Am J Clin Pathol"},{"key":"271_CR89","doi-asserted-by":"crossref","first-page":"e94987","DOI":"10.1371\/journal.pone.0094987","volume":"9","author":"S Linsler","year":"2014","unstructured":"Linsler S, Kraemer D, Driess C et al (2014) Molecular biological determinations of meningioma progression and recurrence. PLoS One 9:e94987","journal-title":"PLoS One"},{"key":"271_CR90","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"65","author":"EA Lusis","year":"2005","unstructured":"Lusis EA, Watson MA, Chicoine MR et al (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121\u20137126","journal-title":"Cancer Res"},{"key":"271_CR91","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A et al (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70:2350\u20132358","journal-title":"Cancer Res"},{"key":"271_CR92","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.18632\/oncotarget.2517","volume":"5","author":"MS Abedalthagafi","year":"2014","unstructured":"Abedalthagafi MS, Merrill PH, Bi WL et al (2014) Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget 5:10596\u201310606","journal-title":"Oncotarget"},{"key":"271_CR93","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000478-200403000-00013","volume":"28","author":"M Hasselblatt","year":"2004","unstructured":"Hasselblatt M, Nolte KW, Paulus W (2004) Angiomatous meningioma: a clinicopathologic study of 38 cases. Am J Surg Pathol 28:390\u2013393","journal-title":"Am J Surg Pathol"},{"key":"271_CR94","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-006-9318-7","volume":"83","author":"R Ketter","year":"2007","unstructured":"Ketter R, Kim YJ, Storck S et al (2007) Hyperdiploidy defines a distinct cytogenetic entity of meningiomas. J Neurooncol 83:213\u2013221","journal-title":"J Neurooncol"},{"key":"271_CR95","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostrom","year":"2001","unstructured":"Bostrom J, Meyer-Puttlitz B, Wolter M et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669","journal-title":"Am J Pathol"},{"key":"271_CR96","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1013863630293","volume":"55","author":"M Simon","year":"2001","unstructured":"Simon M, Park TW, Koster G et al (2001) Alterations of INK4a(p16-p14ARF)\/INK4b(p15) expression and telomerase activation in meningioma progression. J Neurooncol 55:149\u2013158","journal-title":"J Neurooncol"},{"key":"271_CR97","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","volume":"12","author":"A Perry","year":"2002","unstructured":"Perry A, Banerjee R, Lohse CM et al (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183\u2013190","journal-title":"Brain Pathol"},{"key":"271_CR98","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M et al (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24:184\u2013189","journal-title":"Brain Pathol"},{"key":"271_CR99","doi-asserted-by":"crossref","unstructured":"Sahm F, Schrimpf D, Olar A et al (2016) TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst 108","DOI":"10.1093\/jnci\/djv377"},{"key":"271_CR100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ et al (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339:957\u2013959","journal-title":"Science"},{"key":"271_CR101","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS et al (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339:959\u2013961","journal-title":"Science"},{"key":"271_CR102","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ et al (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci USA 110:17426\u201317431","journal-title":"Proc Natl Acad Sci USA"},{"key":"271_CR103","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","volume":"51","author":"DS Huang","year":"2015","unstructured":"Huang DS, Wang Z, He XJ et al (2015) Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. Eur J Cancer 51:969\u2013976","journal-title":"Eur J Cancer"},{"key":"271_CR104","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-015-1454-8","volume":"130","author":"DE Reuss","year":"2015","unstructured":"Reuss DE, Kratz A, Sahm F et al (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130:407\u2013417","journal-title":"Acta Neuropathol"},{"key":"271_CR105","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498","journal-title":"N Engl J Med"},{"key":"271_CR106","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10014-016-0257-5","volume":"33","author":"TM Johanns","year":"2016","unstructured":"Johanns TM, Fu Y, Kobayashi DK et al (2016) High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathol 33:222\u2013227","journal-title":"Brain Tumor Pathol"},{"key":"271_CR107","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458\u2013468","journal-title":"Nat Genet"},{"key":"271_CR108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10014-014-0202-4","volume":"32","author":"Y Kato","year":"2015","unstructured":"Kato Y (2015) Specific monoclonal antibodies against IDH1\/2 mutations as diagnostic tools for gliomas. Brain Tumor Pathol 32:3\u201311","journal-title":"Brain Tumor Pathol"},{"key":"271_CR109","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","volume":"126","author":"F Sahm","year":"2013","unstructured":"Sahm F, Bissel J, Koelsche C et al (2013) AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. Acta Neuropathol 126:757\u2013762","journal-title":"Acta Neuropathol"},{"key":"271_CR110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.pai.0000213114.27978.3a","volume":"15","author":"AM Buccoliero","year":"2007","unstructured":"Buccoliero AM, Gheri CF, Castiglione F et al (2007) Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study. Appl Immunohistochem Mol Morphol 15:353\u2013357","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"271_CR111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/PAI.0b013e318289f490","volume":"22","author":"S Pavelin","year":"2014","unstructured":"Pavelin S, Becic K, Forempoher G et al (2014) The significance of immunohistochemical expression of merlin, Ki-67, and p53 in meningiomas. Appl Immunohistochem Mol Morphol 22:46\u201349","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-016-0271-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:55:58Z","timestamp":1718790958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-016-0271-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1007\/s10014-016-0271-7","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}